Expert consensus on urate‑lowering therapy for high‑risk hyperuricemia (2026 edition)

Xiaoxia Zhu, Yingqian Mo, Lihua Duan, Yufeng Qing, Lie Dai, Zhuoli Zhang, Yan Zhao, Hejian Zou

Open source

DOI
10.1097/cm9.0000000000004167
Published
2026-06-30
Container
Chinese Medical Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/cm9.0000000000004167,
  title = {Expert consensus on urate‑lowering therapy for high‑risk hyperuricemia (2026 edition)},
  author = {Xiaoxia Zhu and Yingqian Mo and Lihua Duan and Yufeng Qing and Lie Dai and Zhuoli Zhang and Yan Zhao and Hejian Zou},
  year = {2026},
  journal = {Chinese Medical Journal},
  doi = {10.1097/cm9.0000000000004167},
  url = {https://doi.org/10.1097/cm9.0000000000004167}
}

RIS

TY  - JOUR
TI  - Expert consensus on urate‑lowering therapy for high‑risk hyperuricemia (2026 edition)
AU  - Xiaoxia Zhu
AU  - Yingqian Mo
AU  - Lihua Duan
AU  - Yufeng Qing
AU  - Lie Dai
AU  - Zhuoli Zhang
AU  - Yan Zhao
AU  - Hejian Zou
PY  - 2026
JO  - Chinese Medical Journal
DO  - 10.1097/cm9.0000000000004167
UR  - https://doi.org/10.1097/cm9.0000000000004167
ER  - 

APA

Zhu, X., Mo, Y., Duan, L., Qing, Y., Dai, L., Zhang, Z., Zhao, Y., & Zou, H. (2026). Expert consensus on urate‑lowering therapy for high‑risk hyperuricemia (2026 edition). Chinese Medical Journal. https://doi.org/10.1097/cm9.0000000000004167

Source records